Pfizer: COVID pill cut hospital, death risk by 90%

Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced it will soon ask the U.S. FDA and international regulators to authorize it. (Nov. 5)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting